Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: zeta1961 who wrote (939)	2/26/2004 10:32:41 AM
From: Jibacoa	Respond to of 1005

Will see what happens at the CC tomorrow.The stock needs to close above $9 in order to break its present downtrend.(Amber lights are still flashing at the DOW and the NAZ.<g.) AUSTIN, Texas--(BUSINESS WIRE)--Feb. 25, 2004--Introgen Therapeutics, Inc. (NASDAQ:INGN - News), a leading developer of biopharmaceutical products , will hold its quarterly conference call to discuss fourth quarter 2003 and year end results on Friday, February 27 2004, at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). biospace.com siliconinvestor.com bigcharts.marketwatch.com bigcharts.marketwatch.com Bernard